273 related articles for article (PubMed ID: 8105867)
1. Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells.
Versantvoort CH; Schuurhuis GJ; Pinedo HM; Eekman CA; Kuiper CM; Lankelma J; Broxterman HJ
Br J Cancer; 1993 Nov; 68(5):939-46. PubMed ID: 8105867
[TBL] [Abstract][Full Text] [Related]
2. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells.
Versantvoort CH; Broxterman HJ; Lankelma J; Feller N; Pinedo HM
Biochem Pharmacol; 1994 Sep; 48(6):1129-36. PubMed ID: 7945406
[TBL] [Abstract][Full Text] [Related]
3. Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug-resistant cell lines using digitonin.
Versantvoort CH; Broxterman HJ; Feller N; Dekker H; Kuiper CM; Lankelma J
Int J Cancer; 1992 Apr; 50(6):906-11. PubMed ID: 1348241
[TBL] [Abstract][Full Text] [Related]
4. Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression.
Versantvoort CH; Broxterman HJ; Pinedo HM; de Vries EG; Feller N; Kuiper CM; Lankelma J
Cancer Res; 1992 Jan; 52(1):17-23. PubMed ID: 1309222
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein.
Castro AF; Altenberg GA
Biochem Pharmacol; 1997 Jan; 53(1):89-93. PubMed ID: 8960067
[TBL] [Abstract][Full Text] [Related]
6. Daunorubicin efflux against a concentration gradient in non-P-glycoprotein multidrug-resistant lung-cancer cells.
Mülder HS; Lankelma J; Dekker H; Broxterman HJ; Pinedo HM
Int J Cancer; 1994 Oct; 59(2):275-81. PubMed ID: 7927929
[TBL] [Abstract][Full Text] [Related]
7. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein.
Benderra Z; Morjani H; Trussardi A; Manfait M
Int J Oncol; 1998 Mar; 12(3):711-5. PubMed ID: 9472114
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cellular glutathione modulates nuclear accumulation of daunorubicin in human MCF7 cells overexpressing multidrug resistance associated protein.
Benderra Z; Trussardi A; Morjani H; Villa AM; Doglia SM; Manfait M
Eur J Cancer; 2000 Feb; 36(3):428-34. PubMed ID: 10708946
[TBL] [Abstract][Full Text] [Related]
9. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
Gupta S; Patel K; Singh H; Gollapudi S
Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
[TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by tyrosine-kinase inhibitors in a non-P-glycoprotein-mediated multidrug-resistant cell line.
Takeda Y; Nishio K; Niitani H; Saijo N
Int J Cancer; 1994 Apr; 57(2):229-39. PubMed ID: 7908894
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase inhibitor-induced alterations of drug uptake, cell cycle and surface antigen expression in human multidrug-resistant (Pgp and MRP) promyelocytic leukemia HL-60 cells.
Sedlák J; Hunáková L; Suliková M; Chorváth B
Leuk Res; 1997 May; 21(5):449-58. PubMed ID: 9225074
[TBL] [Abstract][Full Text] [Related]
13. A plasma membrane 'vacuum cleaner' for daunorubicin in non-P-glycoprotein multidrug-resistant SW-1573 human non-small cell lung carcinoma cells. A study using fluorescence resonance energy transfer.
Mülder HS; van Grondelle R; Westerhoff HV; Lankelma J
Eur J Biochem; 1993 Dec; 218(3):871-82. PubMed ID: 8281939
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
[TBL] [Abstract][Full Text] [Related]
15. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
Friche E; Demant EJ; Sehested M; Nissen NI
Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance-modifying components in human plasma with potential clinical significance.
Mülder HS; Pinedo HM; Timmer AT; Rao BR; Lankelma J
J Exp Ther Oncol; 1996 Jan; 1(1):13-22. PubMed ID: 9414384
[TBL] [Abstract][Full Text] [Related]
17. Acceleration of MRP-associated efflux of rhodamine 123 by genistein and related compounds.
Versantvoort CH; Rhodes T; Twentyman PR
Br J Cancer; 1996 Dec; 74(12):1949-54. PubMed ID: 8980395
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells.
Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A
Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942
[TBL] [Abstract][Full Text] [Related]
19. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate.
Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J
Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520
[TBL] [Abstract][Full Text] [Related]
20. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
Politi PM; Sinha BK
Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
